Analysts Set Ardent Health, Inc. (NYSE:ARDT) PT at $14.21

Ardent Health, Inc. (NYSE:ARDTGet Free Report) has earned an average rating of “Hold” from the fourteen ratings firms that are presently covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $14.2083.

A number of brokerages recently issued reports on ARDT. Wall Street Zen upgraded shares of Ardent Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 16th. Royal Bank Of Canada decreased their target price on shares of Ardent Health from $14.00 to $13.00 and set an “outperform” rating for the company in a research report on Monday, March 9th. UBS Group increased their target price on shares of Ardent Health from $13.00 to $13.50 and gave the company a “buy” rating in a research report on Thursday, May 7th. Leerink Partners decreased their target price on shares of Ardent Health from $16.00 to $15.00 and set an “outperform” rating for the company in a research report on Friday, March 6th. Finally, Zacks Research upgraded shares of Ardent Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 25th.

Check Out Our Latest Report on Ardent Health

Hedge Funds Weigh In On Ardent Health

A number of institutional investors and hedge funds have recently bought and sold shares of ARDT. Goldentree Asset Management LP boosted its position in shares of Ardent Health by 99.7% during the 4th quarter. Goldentree Asset Management LP now owns 2,303,113 shares of the company’s stock valued at $20,302,000 after purchasing an additional 1,150,000 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Ardent Health by 1,684.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock valued at $10,558,000 after purchasing an additional 724,841 shares in the last quarter. Ameriprise Financial Inc. boosted its position in shares of Ardent Health by 75.6% during the 2nd quarter. Ameriprise Financial Inc. now owns 1,634,822 shares of the company’s stock valued at $22,332,000 after purchasing an additional 703,739 shares in the last quarter. Bridgeway Capital Management LLC boosted its position in shares of Ardent Health by 108.2% during the 4th quarter. Bridgeway Capital Management LLC now owns 946,571 shares of the company’s stock valued at $8,358,000 after purchasing an additional 491,961 shares in the last quarter. Finally, Hotchkis & Wiley Capital Management LLC bought a new position in shares of Ardent Health during the 3rd quarter valued at about $6,377,000.

Ardent Health Stock Performance

Shares of ARDT opened at $9.21 on Friday. The firm has a 50-day moving average price of $9.38 and a 200 day moving average price of $9.22. The firm has a market capitalization of $1.32 billion, a PE ratio of 9.69, a P/E/G ratio of 2.05 and a beta of 0.93. The company has a quick ratio of 2.00, a current ratio of 2.12 and a debt-to-equity ratio of 0.62. Ardent Health has a 52-week low of $8.07 and a 52-week high of $15.48.

Ardent Health (NYSE:ARDTGet Free Report) last announced its earnings results on Tuesday, May 5th. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.18 by $0.10. The firm had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.58 billion. Ardent Health had a net margin of 2.09% and a return on equity of 13.85%. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. On average, sell-side analysts anticipate that Ardent Health will post 1.12 earnings per share for the current fiscal year.

Ardent Health Company Profile

(Get Free Report)

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.

Read More

Analyst Recommendations for Ardent Health (NYSE:ARDT)

Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.